Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Rhodioloside inhibits apoptosis of hippocampal?neurons exposed to sevoflurane via cAMP/PKA signaling pathway

Yuqiang Su, Yan Bai, Zhonglei Zheng, Xiaoying Fan

The Second Affiliated Hospital of Xi'an Medical College, Department of Surgical Anesthesia, Xi'an,710038, China;

For correspondence:- Xiaoying Fan Email: dced7848@126.com Tel:+8619654321022

Accepted: 4 May 2020 Published: 30 September 2020

Citation: Su Y, Bai Y, Zheng Z, Fan X. Rhodioloside inhibits apoptosis of hippocampal?neurons exposed to sevoflurane via cAMP/PKA signaling pathway. Trop J Pharm Res 2020; 19(9):1827-1834 doi: 10.4314/tjpr.v19i9.5

© 2020 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: Neural injury affects patients after using inhalational anesthetics such as sevoflurane. Rhodioloside, a compound which is obtained from the Rhodiola rosea plant has been implicated to be the most commonly used psychostimulant that can improve a range of conditions. The study was aimed at finding the molecular mechanism underlying the Rhodioloside treatment of sevoflurane-injured hippocampal neurons.

Methods: Main hippocampal neurons, secluded from Sprague Dawley embryonic rats were employed to create an injury model using 3 % sevoflurane. The sevoflurane-injured hippocampal neurons were treated with varying concentrations (10, 20, 40 and 80 μM/ml) of Rhodioloside to create different experimental groups: RHSD10+SEV, RHSD20+SEV, RHSD40+SEV, RHSD80+SEV, while untreated cells were considered as the Control group. Cell viability was identified using the CCK-8 assay. The CFSE assay was used to verify the promotion function of Rhodioloside on cell differentiation of neurons. FCM assay was employed to determine cell proliferation and apoptosis. expression levels of apoptosis-related factors, like Caspase-3, Bcl-2 and Bax were examined by RT-qPCR, while Western blot was used to measure phosphorylation of PKA.

Results: Rhodioloside stimulated cell viability and prevented cell apoptosis in sevoflurane-injured hippocampal neurons in doses between 10-80 µM. The apoptosis-inhibitory effect of Rhodioloside was observed to be through cAMP/PKA pathway activation. Also, expression levels of Bcl-2, and PKA were enhanced and the level of Caspase-3 and Bax was reduced in a dose-dependent pattern. The PKA inhibitor reversed the above observation in the 40 μM Rhodioloside-treatment.

Conclusion: Rhodioloside promoted cell viability and prevented apoptosis of primary hippocampal neurons injured by sevoflurane, through cAMP/PKA pathway activation. Inhibition of PKA network deteriorated the function of Rhodioloside by stimulating cell apoptosis. Our findings present a novel evidence that Rhodioloside could attenuate neurotoxicity of inhalational anesthetics.

Keywords: Cell apoptosis, cAMP/PKA pathway, Hippocampal?neurons, Rhodioloside, Sevoflurane